1. High Prevalence of PNH-phenotype Cells in Patients Who Received CD19-targeted CAR T-cell Therapy. Issue 9 (11th September 2021) Authors: Yoshihara, Kyoko; Matsuda, Ikuo; Utsunomiya, Nobuto; Samori, Mami; Hirata, Saki; Okada, Masaya; Hirota, Seiichi; Higasa, Satoshi; Yoshihara, Satoshi Journal: HemaSphere Issue: Volume 5:Issue 9(2021) Page Start: e628 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Severe acute heart failure during or following cytokine release syndrome after CAR T-cell therapy. (2022) Authors: Yoshihara, Kyoko; Orihara, Yoshiyuki; Hoshiyama, Tokiko; Tamaki, Hiroya; Sunayama, Isamu; Matsuda, Ikuo; Nishikawa, Akinori; Kumamoto, Tomoko; Samori, Mami; Utsunomiya, Nobuto; Min, Kyung-Duk; Asakura, Masanori; Hirota, Seiichi; Ishihara, Masaharu; Higasa, Satoshi; Yoshihara, Satoshi Journal: Leukemia research reports Issue: Volume 18(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. T‐cell lymphoma, B‐cell lymphoma, and myelodysplastic syndrome harboring common mutations: Trilineage tumorigenesis from a common founder clone. Issue 1 (3rd December 2021) Authors: Yoshihara, Kyoko; Nannya, Yasuhito; Matsuda, Ikuo; Samori, Mami; Utsunomiya, Nobuto; Okada, Masaya; Hirota, Seiichi; Ogawa, Seishi; Yoshihara, Satoshi Journal: EJHaem Issue: Volume 3:Issue 1(2022) Page Start: 211 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗